Thrombotic Microangiopathy: A Devastating Complication After Lung Transplantation. [PDF]
Rosseels W+7 more
europepmc +1 more source
Atypical presentation of H1N1-induced thrombotic microangiopathy with CD46 gene mutation . [PDF]
Pal A+8 more
europepmc +1 more source
Correction: The diagnostic value of skin biopsies in Sneddon syndrome. [PDF]
Starmans NLP+4 more
europepmc +1 more source
Therapeutic Plasma Exchange in a Rare Case of Metastatic Pancreatic Carcinoma Presenting as Thrombotic Microangiopathy and Acute Kidney Injury. [PDF]
Mok TH, Cheung CY.
europepmc +1 more source
Clinical Outcomes and Treatment Strategies of Adult Transplant-Associated Thrombotic Microangiopathy: External Validation of Harmonizing Definitions and High-Risk Criteria. [PDF]
Acosta-Medina AA+19 more
europepmc +1 more source
A Rapid Review of Adenocarcinoma and Pulmonary Tumor Thrombotic Microangiopathy: A Deadly Duo. [PDF]
Gayibov E, Karim AH.
europepmc +1 more source
Striped noncrystalline deposits within the expanded subendothelial space. [PDF]
Ito H, Kannno A, Hirose T, Mori T.
europepmc +1 more source
Related searches:
Thrombotic Microangiopathy in Cancer
Seminars in Thrombosis and Hemostasis, 2019Thrombotic microangiopathy (TMA) is a rare but often devastating complication of cancer and cancer treatment. The syndrome is defined by thrombocytopenia (i.e., a platelet count of 30% decrease from baseline), microangiopathic hemolytic anemia, and some
I. Weitz
semanticscholar +5 more sources